Whether your business operates in Pharma or Biotech, our team advises on corporate and commercial matters, governance, regulatory compliance, intellectual property, data protection, parallel trade, clinical negligence and public procurement.
Pharma & Biotech
We deliver end to end legal services on marketing authorisation under Directive 2001/83/EC and Regulation (EC) 726/2004, on pricing and reimbursement under Law 4472/2017 and Law 5243/2025, on clawback and rebate obligations under Laws 4052/2012 and 4512/2018 and on the new EU pharmaceutical legislation package. We advise on Advanced Therapy Medicinal Products (ATMPs) under Regulation (EC) 1394/2007, including gene therapy, somatic cell therapy and tissue engineered products. We support clients on mRNA technologies, biosimilars under EMA biosimilar guidelines, orphan drugs under Regulation (EC) 141/2000 and personalised medicine. We handle veterinary medicinal products under Regulation (EU) 2019/6, OTC products, cosmetics under Regulation (EC) 1223/2009 and food supplements. Our practice also covers Health Technology Assessment under Regulation (EU) 2021/2282, EU Joint Clinical Assessments and the legal aspects of investigator initiated and sponsor driven clinical trials under Regulation (EU) 536/2014.